Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

LinusBio, a leader in precision exposome medicine, today announced ClearStrand-ASDtm, a first-of-its-kind diagnostic aid for autism spectrum disorder (ASD). ClearStrand-ASD is a biochemical test that ...

Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings ...

Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the call over to Rachel Rodriguez, ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

Harwood works with technology and business leaders to respond to rapid innovation at the intersection of science and technology. His research explores the rise of generative AI and accelerated use of ...

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, but how do chatbots do when the ...